Blood Krebs von den Lungen-6 levels predict treatment response to antifibrotic therapy in patients with idiopathic pulmonary fibrosis

Abstract Background Antifibrotic therapy can slow disease progression (DP) in patients with idiopathic pulmonary fibrosis (IPF). However, the prognostic biomarkers for DP in patients with IPF receiving antifibrotic therapy have not been identified. Therefore, we aimed to evaluate the prognostic effi...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Myeong Geun Choi, Sun Mi Choi, Jae Ha Lee, Joong-Yub Kim, Jin Woo Song
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	BMC 2022-12-01
Цуврал:	Respiratory Research
Нөхцлүүд:	Krebs von den Lungen-6 Idiopathic pulmonary fibrosis Antifibrotic treatment
Онлайн хандалт:	https://doi.org/10.1186/s12931-022-02273-6
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!